NCI Proposes Inviting Academic Labs To Submit New Therapies For Development
In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm
Research Funding: 30 Groups Sign Letter For Double NCI Budget
Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco
Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements
NIH On R29 Phase-Out; Grant Review Appeals Process Changed
Trending Stories
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Scaling excellence: How City of Hope is transforming cancer care delivery